Ming-Chou Lee

Ming-Chou Lee has extensive work experience in the field of molecular diagnostics and product development. Ming-Chou currently serves as the CTO at Exagen Inc. Prior to this, they held the position of Vice President, Molecular Diagnostics Product Development at Prescient Metabiomics. From 2019 to 2020, Ming-Chou Lee worked as the Senior Director at ArcherDX, where they were responsible for driving product development planning and implementation strategy for oncology Companion Diagnostics and NGS based IVD products. Ming-Chou also served as a principal consultant at Dynamic Biotechnology, providing consulting services in IVD, CLIA LDT, POCT product development, quality systems, and regulatory affairs. Ming-Chou Lee's previous experience includes roles such as Vice President of Product Development at MDxHealth, Senior Director of Assay Development at Roka Bioscience, and VP of Assay Development at PrimeraDx. Ming-Chou also worked as the Director of Molecular Diagnostics R&D at Focus Diagnostics, where they led a team in establishing core technology for the company's molecular diagnostics product line. Prior to that, Ming-Chou Lee worked as a Staff Scientist at Beckman Coulter and served as a Group Leader at Industrial Technology Research Institute.

Ming-Chou Lee holds a Ph.D. in Molecular Biology from the University of Alabama at Birmingham. Prior to earning their doctorate, they obtained a Master of Science degree in Microbiology from Texas Tech University. Additionally, they completed their undergraduate studies at National Chung Hsing University, where they earned a Bachelor of Science degree in Plant Pathology. The exact start and end years for each of these educational experiences are not provided.